MichaelEndrodi(Dohnanyi)SalaczMD
Oncology • Pennington, NJNeuro-Oncology
Director, Neuro-Oncology Program Associate Professor of Medicine Rutgers, Cancer Institute of New Jersey Robert Wood Johnson Medical School
Dr. Salacz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Capital Way
Pennington, NJ 08534Phone+1 609-537-6363
Summary
- Dr. Michael Salacz is a neuro-oncologist in Hopewell, NJ and Camden, NJ and is affiliated with Capital Health, Hopewell as well as Cooper Health, Camden. He received his medical degree from Rutgers - New Jersey Medical School and has been in practice 19 years. He specializes in neuro-oncology and is experienced in oligodendroglioma, ependymoma, primary central nervous system lymphoma, neuroblastoma, and glioblastoma multiforme. He has more than 20 publications and over 500 citations.
Education & Training
Medical College of Wisconsin Affiliated HospitalsFellowship, Hematology and Medical Oncology, 2002 - 2005
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 1999 - 2002- University of Cincinnati Medical Center Inc.Internship, Transitional Year, 1998 - 1999
Rutgers New Jersey Medical SchoolClass of 1998
Certifications & Licensure
NJ State Medical License 2020 - 2025
KS State Medical License 2005 - 2021
MO State Medical License 2005 - 2021
NC State Medical License 2007 - 2008
WI State Medical License 2002 - 2005
OH State Medical License 2000 - 2004- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Phase I/II Study To Test The Safety and Efficacy of TVI-Brain-1 As A Treatment For Recurrent Grade IV Glioma Start of enrollment: 2010 Apr 01
Publications & Presentations
PubMed
- 195 citationsFirst results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.Linda M Liau, Keyoumars Ashkan, David D Tran, Jian L Campian, John E Trusheim
Journal of Translational Medicine. 2018-05-29 - 172 citationsTwo cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open...L. Burt Nabors, Karen Fink, Tom Mikkelsen, Danica Grujicic, Rafal Tarnawski
Neuro-Oncology. 2015-05-01 - 23 citationsToward a noncytotoxic glioblastoma therapy: blocking MCP-1 with the MTZ RegimenMichael Salacz, Richard E. Kast, Najmaldin Saki, Ansgar Brüning, Georg Karpel-Massler
Oncotargets and Therapy. 2016-04-27
Journal Articles
- Profiles of Brain Metastases: Prioritization of Therapeutic TargetsRaymond Sawaya, Zoran Gatalica, Isabella C Glitza, John V Heymach, Michael E Salacz, Michael A Davies, Amy B Heimberger, Nuhad K Ibrahim, Jianjun Zhang, Sherise D Ferg..., International Journal of Cancer
Press Mentions
8 Oncologists on the MoveApril 2nd, 2021- Rutgers Cancer Institute of New Jersey Names Director of Neuro-OncologyMarch 24th, 2021
John McCain Has Died. For Brain Cancers like His, 'Research Is Our Only Hope'August 25th, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
